By expenditures
| Name | Title | Type |
|---|---|---|
| Mary McBride | President | Auditee |
| Susan Colladay | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 369507 | 2024 | 2025-09-30 | Gelman Rosenberg & Freedman | $938,281 |
| 323314 | 2023 | 2024-09-30 | Gelman Rosenberg & Freedman | $1.53M |
| 46561 | 2022 | 2023-09-28 | Gelman Rosenberg & Freedman | $883,059 |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 323314 | 2023 | 2024-09-30 | 1077496 | 2023-005 | Significant Deficiency | Yes | CL |
| 323314 | 2023 | 2024-09-30 | 1077495 | 2023-004 | Significant Deficiency | Yes | I |
| 323314 | 2023 | 2024-09-30 | 1077494 | 2023-003 | Significant Deficiency | Yes | L |
| 323314 | 2023 | 2024-09-30 | 1077493 | 2023-005 | Significant Deficiency | Yes | CL |
| 323314 | 2023 | 2024-09-30 | 1077492 | 2023-004 | Significant Deficiency | Yes | I |
| 323314 | 2023 | 2024-09-30 | 1077491 | 2023-003 | Significant Deficiency | Yes | L |
| 323314 | 2023 | 2024-09-30 | 501054 | 2023-005 | Significant Deficiency | Yes | CL |
| 323314 | 2023 | 2024-09-30 | 501053 | 2023-004 | Significant Deficiency | Yes | I |
| 323314 | 2023 | 2024-09-30 | 501052 | 2023-003 | Significant Deficiency | Yes | L |
| 323314 | 2023 | 2024-09-30 | 501051 | 2023-005 | Significant Deficiency | Yes | CL |
| 323314 | 2023 | 2024-09-30 | 501050 | 2023-004 | Significant Deficiency | Yes | I |
| 323314 | 2023 | 2024-09-30 | 501049 | 2023-003 | Significant Deficiency | Yes | L |
| 46561 | 2022 | 2023-09-28 | 615302 | 2022-006 | Significant Deficiency | - | L |
| 46561 | 2022 | 2023-09-28 | 615301 | 2022-005 | Significant Deficiency | - | CL |
| 46561 | 2022 | 2023-09-28 | 615300 | 2022-004 | Significant Deficiency | - | H |
| 46561 | 2022 | 2023-09-28 | 615299 | 2022-003 | Material Weakness | - | I |
| 46561 | 2022 | 2023-09-28 | 615298 | 2022-002 | Material Weakness | - | I |
| 46561 | 2022 | 2023-09-28 | 38860 | 2022-006 | Significant Deficiency | - | L |
| 46561 | 2022 | 2023-09-28 | 38859 | 2022-005 | Significant Deficiency | - | CL |
| 46561 | 2022 | 2023-09-28 | 38858 | 2022-004 | Significant Deficiency | - | H |
| 46561 | 2022 | 2023-09-28 | 38857 | 2022-003 | Material Weakness | - | I |
| 46561 | 2022 | 2023-09-28 | 38856 | 2022-002 | Material Weakness | - | I |